Aminopyrimidines useful as kinase inhibitors

Details for Australian Patent Application No. 2006315334 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Robinson, Daniel; Pinder, Joanne; Miller, Andrew; Fraysse, Damien

Agent Cullens

Pub. Number AU-B-2006315334

PCT Pub. Number WO2007/059299

Priority 60/737,064 16.11.05 US

Filing date 16 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 19 May 2011

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059299 Priority application(s): WO2007/059299

19 May 2011 Application Accepted

  Published as AU-B-2006315334

15 September 2011 Standard Patent Sealed

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315347-Methods and compositions comprising non-natural amino acids

2006315333-Chimeric immunoreceptor useful in treating human cancers